Dr. Nisrine Bou Malhab, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 911 Bypass Rd Bldg A, Pikeville, KY 41501 Phone: 606-430-2208 Fax: 606-218-7508 |
Shadi Falah Obeidat, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 911 Bypass Rd, 8th Floor Clinic Building, Pikeville, KY 41501 Phone: 606-218-3500 |
Azmi Draw, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 10214 Worthington Ln, Prospect, KY 40059 Phone: 502-216-0191 |
Dr. Muhammad H Iqbal, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 793 Eastern Byp, Suite 216, Richmond, KY 40475 Phone: 859-624-6540 Fax: 859-624-6549 |
Mhd Haitham Chaker, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 720 Hospital Dr, Suite 106, Shelbyville, KY 40065 Phone: 502-633-1151 Fax: 502-633-5282 |
Dr. Mateen Ahmed, M.D Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 110 Hardin Lane, Suite10, Somerset, KY 42503 Phone: 606-678-0946 Fax: 606-678-0949 |
Srinivas M Ammisetty, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 9350 Us Hwy 23 South, Suite 104, Stanville, KY 41659 Phone: 606-478-1005 Fax: 606-478-8687 |
Mahmood Alam, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 226 Medical Plaza Lane, Whitesburg, KY 41858 Phone: 606-633-4871 Fax: 606-633-0883 |
Dr. Michael Jeffrey Perlmutter, MD Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1300 W Lexington Ave, Suite 2, Winchester, KY 40391 Phone: 859-901-9907 Fax: 859-901-9904 |
News Archive
QIAGEN today announced the launch of a novel product for extraction of free circulating fragments of tumor- and fetal-derived nucleic acids as well as viral nucleic acids in human blood. Scientists consider these DNA and RNA fragments to have great potential for the highly sensitive and non-invasive diagnosis of a wide range of diseases, including congenital disorders, malignancies such as colon and lung cancer, and infections.
Researchers from the Liverpool School of Tropical Medicine have shown the large potential impact of a completely new type of antimalarial drug that kills mosquitoes, as opposed to existing drugs that target the parasite, to reduce the spread of malaria.
Kaiser Health News staff writer Mary Agnes Carey writes about the questions stemming from the new health reform law: "David wanted to know how the new health care overhaul law would impact retiree health care coverage.
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat infectious diseases and acute cardiovascular disorders, and the University of Massachusetts, Amherst (UMass), have received a Phase 2 Small Business Technology Transfer (STTR) contract in the amount of $750,000.
› Verified 8 days ago